Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing SEMNL Biotechnology is a leading Chinese manufacturer of hydrolyzed fish collagen and other bioactive peptides. Its products are widely used as functional ingredients in nutraceuticals, dietary supplements, foods/beverages, and cosmetics. The company operates GMP-standard facilities with an annual output of up to 3,000 metric tons of hydrolyzed fish collagen. It holds multiple quality certifications (ISO9001/HACCP/BRC/FDA/HALAL) and collaborates with major academic institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing SEMNL Biotechnology.